Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Bibliographic Details
Main Authors:	Bryant, Christopher, Rawlinson, Rebecca, Massey, Andrew J
Format:	Online
Language:	English
Published:	BioMed Central 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137066/

Similar Items

γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments
by: Rawlinson, Rebecca, et al.
Published: (2014)

Novel therapeutic strategies for patients with triple-negative breast cancer
by: Zhang, Jun-Fei, et al.
Published: (2016)

Inhibition of the checkpoint kinase Chk1 induces DNA damage and cell death in human Leukemia and Lymphoma cells
by: Bryant, Christopher, et al.
Published: (2014)

Cripto-1 as a novel therapeutic target for triple negative breast cancer
by: Castro, Nadia P., et al.
Published: (2014)

Triple-Negative Breast Cancer: Adjuvant Therapeutic Options
by: Gucalp, Ayca, et al.
Published: (2011)

Therapeutic landscape in mutational triple negative breast cancer
by: Yaqin Shi, et al.
Published: (2018-07-01)

Tumour growth environment modulates Chk1 signalling pathways and Chk1 inhibitor sensitivity
by: Massey, Andrew J.
Published: (2016)

The Potential Role of Nanotechnology in Therapeutic Approaches for Triple Negative Breast Cancer
by: Johnson, Rebecca, et al.
Published: (2013)

Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibition
by: Audeh, M William
Published: (2014)

Triple-Negative Breast Cancer
by: Chu, Quyen D., et al.
Published: (2012)

Chk1, Chk2, is the amplifier on?
by: Dove, Alan W.
Published: (2001)

Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells
by: Bajrami, Ilirjana, et al.
Published: (2012)

Immune checkpoints: A therapeutic target in triple negative breast cancer
by: Chawla, Akhil, et al.
Published: (2014)

Therapeutic potential of ERK5 targeting in triple negative breast cancer
by: Ortiz-Ruiz, María Jesús, et al.
Published: (2014)

Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
by: Chilà, Rosaria, et al.
Published: (2014)

ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer
by: Li, Ching-Chia, et al.
Published: (2015)

BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
by: Tanino, Hirokazu, et al.
Published: (2016)

Predicting response and survival in chemotherapy-treated triple-negative breast cancer
by: Prat, A, et al.
Published: (2014)

Triple Negative Breast Cancer – An Overview
by: Aysola, Kartik, et al.
Published: (2013)

Revealing targeted therapeutic opportunities in triple-negative breast cancers: A new strategy
by: Poage, Graham M, et al.
Published: (2013)

Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer
by: Inoue, Satoshi, et al.
Published: (2012)

Update on triple-negative breast cancer: prognosis and management strategies
by: Brouckaert, Olivier, et al.
Published: (2012)

Cross-species genomic and functional analyses identify a combination therapy using a CHK1 inhibitor and a ribonucleotide reductase inhibitor to treat triple-negative breast cancer
by: Bennett, Christina N, et al.
Published: (2012)

Current Status of Poly(ADP-ribose) Polymerase Inhibitors as Novel Therapeutic Agents for Triple-Negative Breast Cancer
by: Hiller, David J., et al.
Published: (2012)

Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options
by: Gasparini, Pierluigi, et al.
Published: (2014)

CDK4 regulates cancer stemness and is a novel therapeutic target for triple-negative breast cancer
by: Dai, Meiou, et al.
Published: (2016)

Fascin‐1 as a novel diagnostic marker of triple‐negative breast cancer
by: Wang, Chao‐Qun, et al.
Published: (2016)

Novel genes associated with lymph node metastasis in triple negative breast cancer
by: Mathe, Andrea, et al.
Published: (2015)

Identification of novel long non-coding RNAs in triple-negative breast cancer
by: Shen, Xiaokun, et al.
Published: (2015)

Novel therapy for locally advanced triple-negative breast cancer
by: YAMADA, ATSUKO, et al.
Published: (2015)

Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas
by: Kuo, Wen-Hung, et al.
Published: (2012)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
by: Lv, Mingming, et al.
Published: (2016)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
by: Swanner, Jessica, et al.
Published: (2015)

The Triple-Negative Breast Cancer Database: an omics platform for reference, integration and analysis of triple-negative breast cancer data
by: Raju, Rajesh, et al.
Published: (2014)

Inhibition of iNOS as a novel effective targeted therapy against triple-negative breast cancer
by: Granados-Principal, Sergio, et al.
Published: (2015)

Triple negative breast cancer: The role of metabolic pathways
by: Dean, S.J.R., et al.
Published: (2014)

Management Options in Triple-Negative Breast Cancer
by: Minami, Christina A., et al.
Published: (2011)

Milking the stroma in triple-negative breast cancer
by: Thompson, Alastair M., et al.
Published: (2012)

BRCA2 Mutations and Triple-Negative Breast Cancer
by: Meyer, Peter, et al.
Published: (2012)

Targeting EGFR in Triple Negative Breast Cancer
by: Ueno, Naoto T., et al.
Published: (2011)